Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

127.90
Delayed Data
As of Dec 02
 +0.18 / +0.14%
Today’s Change
126.39
Today|||52-Week Range
196.47
-33.37%
Year-to-Date
Can Illumina Regain Its Mojo?
Dec 03 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks to Buy on Sale
Nov 29 / MotleyFool.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
Attention, Biotech Investors: Black Friday Is Already Here
Nov 21 / MotleyFool.com - Paid Partner Content
3 Ways Pacific Biosciences of California Can Rebound in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close127.72
Today’s open127.99
Day’s range126.91 - 128.56
Volume1,594,707
Average volume (3 months)1,368,693
Market cap$18.8B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+0.30%
Earnings growth (next 5 years)+11.61%
Revenue growth (last year)+19.25%
P/E ratio42.9
Price/Sales12.89
Price/Book10.14

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp-0.47-0.44%
NBIXNeurocrine Bioscienc...+0.01+0.02%
XONIntrexon Corp+0.44+1.58%
BLUEbluebird bio Inc+1.10+1.60%
Data as of 4:02pm ET, 12/02/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.82
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
EVP, Chief Financial &
Administrative Officer
Marc A. Stapley
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs